Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  QJM : monthly journal of the Association of Physicians

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/QJMED/HCL059PMID 16766516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic effects of carvedilol vs. metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial

  2005cited by this paper
• The importance of blood pressure control in the patient with diabetes.

  2004cited by this paper
• Long-term hemodynamic effects of antihypertensive treatment

  2004cited by this paper
• Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

  2004cited by this paper
• A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

  2003cited by this paper
• 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

  2003cited by this paper
• Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Vascular function, insulin resistance and fatty acids

  2002cited by this paper
• Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

  2000cited by this paper
• Antihypertensive therapy and the risk of type 2 diabetes mellitus.

  2000cited by this paper
• Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus

  2000cited by this paper
• Insulin, nitric oxide and the sympathetic nervous system: at the crossroads of metabolic and cardiovascular regulation.

  1999cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper
• Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.

  1998cited by this paper
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

  1998cited by this paper
• Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities.

  1998cited by this paper
• Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

  1998cited by this paper
• Metabolic and Cardiovascular Effects of Carvedilol and Atenolol in Non-Insulin-Dependent Diabetes Mellitus and Hypertension

  1997cited by this paper
• Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

  1997cited by this paper
• Role of central neural mechanisms in the regulation of hepatic glucose metabolism.

  1997cited by this paper
• Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study

  1997cited by this paper
• Differential effect of chronic treatment with two beta‐blocking agents on insulin sensitivity: the carvedilol‐metoprolol study

  1996cited by this paper
• Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.

  1996cited by this paper
• Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment

  1995cited by this paper
• Metabolic effects of an increase of sympathetic activity in healthy humans.

  1995cited by this paper
• Prevention of coronary heart disease in clinical practice

  1994cited by this paper
• Acute noradrenergic activation induces insulin resistance in human skeletal muscle.

  1994cited by this paper
• Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension.

  1994cited by this paper
• Treatment with a β-blocker with β2-agonism improves glucose and lipid metabolism in essential hypertension

  1994cited by this paper
• Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients.

  1992cited by this paper
• The metabolic and circulatory response to beta-blockade in hypertensive men is correlated to muscle capillary density.

  1992cited by this paper
• Clinical review 26: Insulin resistance in obese and nonobese man.

  1991cited by this paper
• Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

  1991cited by this paper
• Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

  1991cited by this paper
• Long term propranolol treatment and changes in body weight after myocardial infarction.

  1990cited by this paper
• Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.

  1989cited by this paper
• Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.

  1989cited by this paper
• Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

  1989cited by this paper
• Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension

  1988cited by this paper
• Acute and Long‐Term Hemodynamic Effects of Carvedilol, a Combined &bgr;‐Adrenoceptor Blocking and Precapillary Vasodilating Agent, in Hypertensive Patients

  1987cited by this paper
• Effect of beta and beta2 adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion.

  1975cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Effect of Bisoprolol Versus Other Beta-Blockers on Glycemic Control and Metabolic Parameters in Type 2 Diabetes: A Retrospective Cohort Study.

  2025cites this paper
• Role of β and α1-adrenoceptors in pancreatic regulation of glucose homeostasis, apoptosis, and fibrosis in dexamethasone-treated rats: A new insight into β-arrestin2 crosstalk with cAMP, PKA-ERK1/2-CREB, and PKB-FOXO1 signaling pathways

  2025cites this paper
• Prevalence and factors associated with hyperglycemia among persons living with HIV/AIDS on dolutegravir-based antiretroviral therapy in Uganda

  2024cites this paper
• A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment

  2024cites this paper
• Guideline-directed antihypertensive medication use among young adult participants with uncontrolled hypertension at enrollment in the MyHEART study

  2024cites this paper
• The effects of antihypertensive drugs on glucose metabolism

  2024cites this paper
• Andere spezifische Diabetesformen und exokrine Pankreasinsuffizienz (Update 2023)

  2023cites this paper
• Clinical profile of patients with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome in Japan: a multicenter retrospective cohort study

  2023cites this paper
• Clinical Characteristics and Prognosis of Patients with Multi-Vessel Coronary Spasm in Comparison with Those in Patients with Single-Vessel Coronary Spasm

  2022cites this paper
• Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris

  2022cites this paper
• Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure

  2021cites this paper
• Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis

  2021cites this paper
• Post-transplantation diabetes mellitus after kidney transplantation and its related factors in Iranian patients: a retrospective single-center study

  2020cites this paper
• Hypertension and Diabetes

  2020cites this paper
• β-Blockers in Metabolic and Endocrine Perspectives

  2020cites this paper
• Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.

  2019cites this paper
• Hypertension and Diabetes

  2019cites this paper
• Comparison of the Effects of Metoprolol and Bisoprolol on Lipid and Glucose Profiles in Cardiovascular Patients.

  2019cites this paper
• Alterations in the Metabolism of Carbohydrates in Hypertensives Treated with Atenolol

  2019cites this paper
• Andere spezifische Diabetesformen und exokrine Pankreasinsuffizienz (Update 2019)

  2019cites this paper
• Beta blockers in patients with end‐stage renal disease—Evidence‐based recommendations

  2018cites this paper
• Drug treatment of hypertension in older patients with diabetes mellitus

  2018cites this paper
• CORRELATION OF ANTIHYPERTENSIVE DRUGS AND NEW ONSET DIABETES: A REVIEW

  2017cites this paper
• The Protective Impact of Vitamin E against Atenolol Effect on Reproductive Efficiency in Male Rats

  2017cites this paper
• [Carvedilol in the everyday interventional cardiology practice].

  2017cites this paper
• A review of chemical therapies for treating diabetic hypertension

  2017cites this paper
• Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol

  2017cites this paper
• Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients

  2016cites this paper
• Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.

  2016cites this paper
• Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study

  2016cites this paper
• Comparison between Vasodilating and Nonvasodilating Beta Blockers on Blood Glucose and Lipid Profiles in Normal Albino Rats

  2016cites this paper
• Melatonin Pathway and Atenolol‐Related Glucose Dysregulation: Is There a Correlation?

  2016cites this paper
• Clinically and pharmacologically relevant interactions of antidiabetic drugs

  2016cites this paper
• Drug‐Induced Diabetes

  2016cites this paper
• Mota-Carmo M. Nebivolol Improves Insulin Sensitivity in High-Sucrose Diet and Spontaneously Hypertensive Rats through a Nitric Oxide Independent Mechanism JCvD 2016. Inpress. I. INTRODUCTION ebivolol is a -1 selective adrenergic receptor antagonist with nitric oxide (NO)-mediated vasodilatory proper

  2016cites this paper
• Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis.

  2015cites this paper
• β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature

  2015cites this paper
• Age, the Number of Medicines Taken and Comorbidities are Associated with Changes of Fasting Blood Glucose Levels in Elderly Diabetics Taking Propranolol and Hydrochlorothiazide

  2015cites this paper
• Blutzuckerprobleme durch die Hintertür

  2014cites this paper
• Treatment of Hypertension in Obese Patients

  2013cites this paper
• Metabolisches Syndrom und antihypertensive Therapie

  2013cites this paper
• Effects of Nebivolol on Aortic Compliance in Patients With Diabetes and Maximal Renin Angiotensin System Blockade: The EFFORT Study

  2013cites this paper
• Obesity-Associated Hypertension

  2013cites this paper
• Use of carvedilol in hypertension: an update

  2012cites this paper
• Vasodilating versus First-Generation β-Blockers for Cardiovascular Protection

  2012influential citation
• Antiischemic effects of metoprolol and the risk of carbohydrate metabolism disturbances in angina patients

  2012cites this paper
• Management of hypertension in diabetic patients: outstanding issues

  2011cites this paper
• Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review.

  2010cites this paper
• Antihypertensive Treatment, High Triglycerides, and Low High-Density Lipoprotein Cholesterol and Risk of Ischemic Heart Disease Mortality: A 16-Year Follow-Up in the Copenhagen Male Study

  2010cites this paper
• Efficacy, tolerability and safety of nebivolol in patients with hypertension and diabetes: a post-marketing surveillance study

  2010cites this paper
• Secondary Causes of Diabetes Mellitus

  2010cites this paper
• Beta-blockers in the management of cardiovascular diseases

  2010cites this paper
• Treatment of hypertension in patients with diabetes--an update.

  2010cites this paper
• Atenolol Exposure and Risk for Development of Adverse Metabolic Effects: A Pilot Study

  2010cites this paper
• Efficacy, tolerability and safety of nebivolol in patients with hypertension and diabetes: a post-marketing surveillance study.

  2010cites this paper
• Effects of β-blockers on glucose and lipid metabolism

  2010cites this paper
• Interaction between the UCP2 -866 G>A polymorphism, diabetes, and β-blocker use among patients with acute coronary syndromes

  2010cites this paper
• Are Tolerability Concerns a Class Effect of Beta-Blockers in Treating Patients with Hypertension?

  2009cites this paper
• The effectiveness of beta adrenoceptor antagonists on progression of insulin resistance and type 2 diabetes in high fat diet-fed rats.

  2009cites this paper
• Treatment of hypertension in patients with diabetes-an update.

  2009cites this paper
• Insufficient Control of Blood Pressure and Incident Diabetes

  2009cites this paper
• Management of hypertension in patients with diabetes: the place of angiotensin‐II receptor blockers

  2009cites this paper
• Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.

  2009cites this paper
• An In-depth Analysis of Vasodilation in the Management of Hypertension: Focus on Adrenergic Blockade

  2009cites this paper
• The β2 Adrenergic Receptor Gln27Glu Polymorphism Affects Insulin Resistance in Patients With Heart Failure: Possible Modulation by Choice of Beta Blocker

  2008cites this paper
• The effects of resistance training on individuals with clusters of metabolic risk factors : focus on functional capacities, clinical outcomes and quality of life

  2008cites this paper
• Carvedilol in hypertension treatment

  2008cites this paper
• Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.

  2008influential citation
• Expert Opinion: Beta‐Blockers for Migraine

  2008cites this paper
• Chapter 51 – Diuretics and β-Blockers

  2008cites this paper
• ASH Position Paper: Treatment of Hypertension in Patients With Diabetes—An Update

  2008cites this paper
• The editor's roundtable: revisiting the role of beta blockers in hypertension.

  2007cites this paper
• Intrauterine growth after uterine artery ligation in rats: dependence on the fetal position in the uterine horn and need for prenatal marking of the animals.

  2007cites this paper
• Blokatori beta-receptora i arterijska hipertenzija: jesu li dileme opravdane?

  2007cites this paper
• Are antihypertensive drugs associated with an increased risk of incident type 2 diabetes?

  2007cites this paper
• Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.

  2007cites this paper
• eta-blockers in the management of cardiovascular iseases

  year unknowncites this paper